This year Philips will launch a new system that is faster, simpler and more cost-effective than the current laboratory tests. A heart infarct can be diagnosed with the Minicare-system with a simple finger prick, within just a few minutes. The handheld device Minicare I-20 is the result of ten years of intensive research, including research done within NanoNextNL. Read the NanoNextNL highlight Drop of blood reveals heart infarct.
Efficiency and quality within healthcare
The Minicare I-20 fits in the trend towards point-of-care medical applications. These systems are faster, simpler and more cost-effective than the current laboratory tests. They speed up clinical decisions but also achieve higher efficiency and quality within healthcare. That applies not just to hospitals but to other locations as well. For example, general practitioners will be able to test for more things themselves and establish a diagnosis straightaway.
Further applications of developed technology
When Minicare I-20 is launched on the market, the work on the technology will certainly not be finished yet. Philips collaborates with universities and other companies on a further expansion of the possibilities. Being able to measure several different proteins can help with diagnosing psychological disorders or brain damage, by a finger prick of blood.